文献速递耳科与耳神经

非处方助听器:是否安全有效?

Over-The-Counter Hearing Aids: Are They Safe and Effective?
PubMed 文献 · Otolaryngol Head Neck Surg · 2024-05-20

本研究采用比较有效性模型,在学术听力学中心使用 AudioScan Verifit 2 Testbox 软件比较处方助听器与非处方助听器在三种听力损失曲线下的安全性和有效性。结果显示,在 8000 Hz 频率下,对于两种下坡型听力损失,处方助听器比非处方助听器离安全阈值更远(48 vs 30.5 dB,P = .04;51 vs 32.5 dB,P = .03),且在 3 个测试点具有统计学显著优势;非处方助听器测试点与目标点差异通常更大。结论认为两者安全性相当,但非处方助听器有效性稍差,需进一步评估其有效性。

要点

  • 在8000 Hz下,两种下坡型听力损失中处方助听器距安全阈值更远。
  • 处方助听器在3个测试点具有统计学显著优势。
  • 非处方助听器测试点与目标点差异通常更大。

核心结论

  • 非处方助听器与处方助听器安全性相当,但非处方助听器有效性稍差。
  • 需要进一步评估非处方助听器的有效性,以确保其提供不同听力损失类型所需的增益。

研究设计与样本

  • 研究设计为比较有效性模型,在学术听力学中心进行。
  • 使用 AudioScan Verifit 2 Testbox 软件比较处方助听器和非处方助听器的安全性和有效性。
  • 分析了三种听力损失类型:下坡型、陡下坡型和反坡型。
  • 有效性在3个音量输入下测试,通过计算设备产生的测试点与软件估计的目标点的平均差异来测量。
  • 安全性通过计算测试点与软件产生的最大安全听力水平的平均差异来评估。

主要发现

  • 在8000 Hz频率下,对于两种下坡型听力损失模式,处方助听器比非处方助听器离安全阈值更远(48 vs 30.5 dB,P = .04;51 vs 32.5 dB,P = .03)。
  • 处方助听器在3个测试点具有统计学显著优势。
  • 非处方助听器测试点与目标点之间的差异通常更大。

局限性

  • 需要进一步评估非处方助听器的有效性,以确保其提供不同听力损失类型所需的增益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: In 2022, the Food and Drug Administration established a new regulatory category for over-the-counter (OTC) hearing aids for mild to moderate hearing loss. Herein, we aim to better compare the safety and efficacy of these devices to that of prescription hearing aids. STUDY DESIGN: Comparative-effectiveness model. SETTING: Academic Audiology Center. METHODS: The safety and efficacy of prescription and OTC hearing aids was compared using the AudioScan Verifit 2 Testbox software. Three types of hearing loss (downsloping, sharp downsloping, and reverse sloping) were analyzed. Efficacy was tested at 3 volume inputs and was measured by calculating the average difference in test points (produced by the devices) and target points (estimated by the software). Safety was assessed by calculating the average difference in test points and the maximally safe hearing level (produced by the software). RESULTS: Prescription hearing aids were found to have a better safety profile by being further from the safety threshold compared to OTC devices at the 8000 Hz frequency for the 2 types of downsloping hearing loss patterns studied (48 vs 30.5 dB, P = .04; 51 vs 32.5 dB, P = .03). Prescription hearing aids also carried a statistically significant advantage at 3 test points. OTC hearing aids generally had a greater difference between test and target points. CONCLUSION: OTC and prescription hearing aids are comparably safe, though OTC hearing aids are slightly less efficacious. Further evaluation of the OTC hearing aid efficacy is warranted to ensure it provides the gain of benefit needed for different types of hearing loss.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Shah R, Wilkins SG, Panth N, et al. Over-The-Counter Hearing Aids: Are They Safe and Effective? Otolaryngol Head Neck Surg. 2024. PMID: 38769863. doi:10.1002/ohn.817

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。